FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology and can be used for treatment of the patients suffering from IIIB-stage Hodgkin's lymphoma (IIIB HL). Method is implemented as follows. A specific patient is examined to estimate degree of regression of the measured lesion foci of Hodgkin's lymphoma at relieving intoxication symptoms after 2-4 cycles of the combined chemotherapy. After regression of the measured lesion foci is not less than 75%, radiation therapy is applied in extent of total or subtotal irradiation of lymph nodes in a dose 36-40 Gy.
EFFECT: method allows improving clinical effectiveness of chemoradiation therapy due to individualised detection of IIIB HL patients with indications for radiation therapy following the combined chemotherapy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OPTIMISATION OF HODGKIN'S LYMPHOMA OF IIIA STAGE TREATMENT IN ADULTS | 2009 |
|
RU2400266C1 |
| METHOD OF TREATING STAGE IIA HODGKIN'S LYMPHOMA | 2011 |
|
RU2457874C1 |
| METHOD FOR TREATING PATIENTS FOR MALIGNANT LYMPHOMAS WITH RADIATION | 2004 |
|
RU2278707C2 |
| METHOD OF ESTIMATING EFFICIENCY OF TREATING PATIENTS WITH HODGKIN'S LYMPHOMA | 2009 |
|
RU2405451C1 |
| METHOD OF ESTIMATION TUMOUR MASS REGRESSION IN CASE OF HODGKIN LYMPHOMA | 2011 |
|
RU2462192C1 |
| METHOD OF PREDICTION OF SENSITIVITY TO ANTICANCER THERAPY OF HODGKIN'S LYMPHOMA | 2008 |
|
RU2393890C1 |
| METHOD OF COMBINED TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER | 2020 |
|
RU2725079C2 |
| METHOD FOR COMBINED TREATMENT OF PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER USING NEOADJUVANT RADIATION THERAPY AND CONSOLIDATING CHEMOTHERAPY | 2021 |
|
RU2770989C2 |
| METHOD OF COMBINATION THERAPY APPLIED FOR LOCALLY ADVANCED CERVICAL CARCINOMA TYPES | 2006 |
|
RU2325199C2 |
| METHOD OF TREATMENT TACTICS OPTIMISATION IN CASE OF HODGKIN'S LYMPHOMA IN CHILDREN AND TEENAGERS | 2007 |
|
RU2373836C2 |
